Rose Duesterwald

1 week ago | whatnext.com | Rose Duesterwald

Current treatments have not been effective against cancers of the female reproductive system. The result is that ovarian cancer remains a primary cause of death from cancers that have metastasized (spread). A New DirectionRecently a study identified an essential factor indicating a promising new path for targeted strategies. Targeted therapy, a treatment using drugs to attack cancer cells, differentiates them from healthy cells.

1 week ago | patientworthy.com | Rose Duesterwald

This week, the FDA the first blood-based diagnostic test for Alzheimer’s disease (AD). The test, known as “Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio,” is designed to detect amyloid plaques identified in adults over 55 who have exhibited AD symptoms. This will reduce reliance on PET scans. According to Dr. Howard Fillit, an AD Foundation science official, over seven million people in the United States are known to have the disorder, and that number is on track to double by 2050.

2 weeks ago | whatnext.com | Rose Duesterwald

With their findings recently published in Medical Xpress, a team of researchers in Cambridge, UK have identified a treatment approach that has a positive effect on breast cancer survival. Patients were recruited from 23 NHS sites across the UK. Researchers conducting the Partner clinical trial explored the efficacy of combining the drug Olaparib with chemotherapy in the treatment of early-stage breast cancer, especially for patients who had inherited BRCA mutations.

2 weeks ago | patientworthy.com | Rose Duesterwald

In 2023, Marley Mansour of Rowlett, Texas and her family were told that Marley had an extremely rare genetic condition called NARS1 disorder. Now, Marley is the world’s first person to be treated for this rare disorder. Marley’s family spent years searching for answers but were unable to find any. The family was told Marley’s disorder is rare and disrupts protein production which leads to various neurological and developmental challenges.

3 weeks ago | patientworthy.com | Rose Duesterwald

Raiden Messerli and his family thought that he had an ordinary case of the flu. Brandi Lewis, Raiden’s mother, discussed in an interview with KCCI8 News how she still vividly remembers the shocked feeling that accompanied the actual diagnosis: Raiden was experiencing Stage 5 kidney failure, otherwise known as end-stage kidney disease. A senior in high school, Raiden is now three months past that diagnosis.